Skip to main content Skip to footer
Memorial Sloan Kettering Cancer Center

Sloan Kettering Institute

  • MSKCC.org Home
  • Find a Researcher
  • Contact Us
What can we help you find today?
  • About Us
  • Research
  • Education & Training
  • News & Events
  • Open Positions
    • MSKCC.org Home
    • Find a Researcher
    • Contact Us
  • Sloan Kettering Institute

Search

  • All
  • Diseases (943)
  • Doctors (2487)
  • Labs (173)
  • Locations (79)
  • News (2842)
Language
for NewsXClear filters
Show 2842 results
Displaying 541–550 of 2842 results.
NewsXReset
MSK News
Weeds in the Garden: A New Research Era To Understand Cancer’s Ecosystem

This new era of cancer research investigates how the disease in certain locations interacts with all the body’s systems. Focusing on cancer’s ecosystem promises to reveal lifesaving insights, especially into metastasis.

News
Epidural Analgesia Unnecessary in Minimally Invasive Lobectomy

The routine use of epidural analgesia for patients with non-small cell lung cancer who undergo a minimally invasive lobectomy is not warranted.

News
微创肺叶切除术中不必要的硬膜外镇痛

不建议对行微创肺叶切除术的非小细胞肺癌患者常规应用硬膜外镇痛。

News
Large Study Pinpoints Genetic Changes Underlying Drug Resistance in the Most Common Type of Breast Cancer

Scientists are learning how estrogen receptor-positive breast cancer evolves to thwart hormonal therapies and are developing ways to stop it.

News
Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast, Second in the Nation, and First for Urology Care by U.S. News & World Report

Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.

News
Findings from People with Acute Myeloid Leukemia Point to a New Understanding of Drug Resistance

Drug resistance is a formidable challenge in cancer treatment. A drug called enasidenib (Idhifa®) was approved by the US Food and Drug Administration last year for the treatment of people with a form of acute myeloid leukemia (AML) that’s driven by a mutation in the gene IDH2. About 15 percent of people with AML have this mutation. Research led by Memorial Sloan Kettering Cancer Center (MSK) reports that people who take enasidenib can develop resistance to it — in a way never seen before. Enasidenib works differently than most cancer drugs. Rather than killing leukemia cells, it turns them into normal blood cells. The discovery of this unique resistence may lead to more-precise treatments for people with AML in the future.

News
New MSK Initiative Focuses on the Early Detection and Prevention of Cancer

Because cancer is more treatable when it’s caught early, MSK’s new Precision Interception and Prevention initiative focuses on early detection.

News
MSK Innovation: Novel System Could Double Mechanical Ventilator Capacity

A new mechanical ventilator system designed by anesthesiologists and biomedical engineers at Memorial Sloan Kettering Cancer Center (MSK) has the ability to support two intubated patients simultaneously while compensating for variability in each patient’s size, weight, and pulmonary needs.

News
Questions To Ask an Oncologist During Your First Visit After a Cancer Diagnosis

Learn what to ask a cancer doctor at your first appointment, such as whether you need additional tests to clarify the diagnosis or guide your treatment.

News
Preguntas para hacerle al oncólogo durante la primera consulta luego de recibir un diagnóstico de cáncer

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Current page 55
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • …
  • Next page ››
  • Last page Last »
  • About Us
    • Overview
    • Leadership
    • Administration
    • History
    • Contact Us
      • Instagram
      • Facebook
      • X
      • YouTube
      • Linkedin
  • Research
    • Overview
    • Research programs
    • Research labs
    • Core facilities & resources
  • Education & Training
    • Overview
    • Postdoctoral training
    • Gerstner Sloan Kettering Graduate School
    • Joint graduate programs
    • Programs for college & high school students
  • News & Events
    • Overview
    • Seminars & events
  • Open Positions
    • Overview
    • Faculty positions
    • Postdoctoral positions
Memorial Sloan Kettering Cancer Center
  • Communication preferences
  • Cookie preferences
  • Legal disclaimer
  • Accessibility Statement
  • Privacy policy
  • Public notices
© 2026 Memorial Sloan Kettering Cancer Center
  • Log in drupal-54dc9659b7-6vhkb